Skip to search formSkip to main contentSkip to account menu

DaunoXome

National Institutes of Health

Related topics

Related topics

5 relations
25 ML Daunorubicin Liposomal 2 MG/ML Injection [DaunoXome]Daunorubicin HydrochlorideDaunorubicin Liposomal Injection [DaunoXome]

Broader (2)

DaunorubicinDaunorubicin Liposomal

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2006
2006
Long Term Follow-Up of the Gimema GSI 103 AMLE Randomized Trial: Daunoxome Seems To Improve Disease-Free Survival (DFS) of Elderly Patients with Acute Myelogenous Leukemia (AML).
The GSI 103 AMLE was a randomized phase III clinical trial to explore the efficacy of DaunoXome (DNX) versus Daunorubicin (DNR… 
2006
2006
Effect of amifostine on the cytotoxicity of daunorubicin and daunoxome in tumor and normal cells.
Anthracyclines are powerful cytotoxic agents, used as first-line treatment of leukemias and many other tumors, but host-tissue… 
2005
2005
Treatment of relapsed acute myelogeneous leukaemia with MLL/AF6 fusion after stem cell transplantation by intensive reinduction followed by adoptive immunotherapy
Treatment of relapsed acute myelogeneous leukaemia with MLL/ AF6 fusion after stem cell transplantation by intensive reinduction… 
2005
2005
Effect of amifostine on the cytotoxicity of daunorubicin and daunoxome in tumor and normal cells
Anthracyclines are powerful cytotoxic agents, used as first-line treatment of leukemias and many other tumors, but host-tissue… 
Highly Cited
2003
Highly Cited
2003
Pilot study of gemtuzumab ozogamicin, liposomal daunorubicin, cytarabine and cyclosporine regimen in patients with refractory acute myelogenous leukemia.
2001
2001
Liposomal Daunorubicin (Daunoxome) in Combination with Cyclophosphamide, Vincristine and Prednisolone (COP-X) as Salvage Therapy in Poor-Prognosis Non-Hodgkins Lymphoma
We treated 33 patients with a variant of the standard 3 weekly CHOP regime, replacing doxorubicin with liposomal daunorubicin… 
2001
2001
Separation and determination of liposomal and non-liposomal daunorubicin from the plasma of patients treated with Daunoxome.
2000
2000
Liposome encapsulated daunorubicin (daunoxome) for acute leukemia.
2000
2000
Combination of liposomal daunorubicin (daunoxome), fludarabine and cytarabine as salvage therapy in relapsed and refractory acute leukemia
Highly Cited
1999
Highly Cited
1999
Liposome‐encapsulated daunorubicin for PGP‐related multidrug resistance
The possibility that Daunoxome (DNX), a combination of daunorubicin (DNR) with a liposomal targeting system, escapes PGP was… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)